Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Adacel Polio
Active Ingredients:	Diphtheria toxoid, adsorbed 2IU Pertactin 3mcg Pertussis filamentous haemagglutinin 5mcg Pertussis fimbriae 2+3 5mcg Pertussis toxoid, adsorbed 2.5mcg Polio virus type 1 40DAgU Polio virus type 2 8DAgU Polio virus type 3 32DAgU Tetanus toxoid 20IU
Dosage Form:	Suspension for injection
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:	Sanofi Pasteur Limited, Toronto, Canada

*Product:*	Bepanthen tattoo
Active Ingredient:	Dexpanthenol 50mg/g
Dosage Form:	Topical ointment
New Zealand Sponsor:	Bayer New Zealand Limited
Manufacturer:	GP Grenzach Produktions GmbH, Grenzach-Wyhlen, Germany

*Product:*	Trazimera
Active Ingredient:	Trastuzumab 150mg
Dosage Form:	Powder for infusion concentrate
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Pfizer Manufacturing Belgium NV, Puurs, Belgium

*Product:*	Trazimera
Active Ingredient:	Trastuzumab 440mg
Dosage Form:	Powder for infusion concentrate with diluent
New Zealand Sponsor:	Pfizer New Zealand Limited
Manufacturer:	Pfizer Manufacturing Belgium NV, Puurs, Belgium

Dated this 5th day of September 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule